WatchGov

Tennessee bills · 114th Regular Session (2025-2026)

Tennessee SB 421

Opioids - As enacted, clarifies that a physician licensed in this state is the only healthcare provider authorized to prescribe a buprenorphine product for a FDA-approved use in recovery or medication-assisted treatment; revises criteria for providers not licensed in this state to prescribe a buprenorphine product for the treatment of opioid use disorder. - Amends TCA Title 33; Title 41; Title 53 and Title 63.

  1. Introduced
  2. In committee
  3. Passed Senate
  4. Passed House
  5. To Governor
  6. Became law

Sponsors

Summary

No official summary is available for this bill.

Latest action(Apr 28, 2025): Comp. became Pub. Ch. 295

Read the official text

Text versions

Roll-call votes

State vote data last updated Oct 27, 2026, 8:04 AM.

DateVoteResultYour legislators
Mar 11, 2025
Senate
SENATE JUDICIARY COMMITTEE: Recommended for passage with amendment/s, refer to Senate Calendar Committee Ayes 9, Nays 0 PNV 0 3/11/2025 PassedpassSet your home in Tennessee to see

Actions